107 related articles for article (PubMed ID: 1979555)
1. Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL.
Hamann GL; Egan TM; Wells BG; Grimmig JE
J Clin Psychiatry; 1990 Dec; 51(12):502-4. PubMed ID: 1979555
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol decanoate: injection site reactions.
Maharaj K; Guttmacher LB; Moeller R
J Clin Psychiatry; 1995 Apr; 56(4):172-3. PubMed ID: 7713859
[No Abstract] [Full Text] [Related]
3. Injection site reactions.
Hay J
J Clin Psychiatry; 1992 Jul; 53(7):256. PubMed ID: 1353493
[No Abstract] [Full Text] [Related]
4. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
Roose K
Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
[TBL] [Abstract][Full Text] [Related]
6. High incidence of haloperidol decanoate injection site reactions.
Reinke M; Wiesert KN
J Clin Psychiatry; 1992 Nov; 53(11):415-6. PubMed ID: 1459975
[No Abstract] [Full Text] [Related]
7. Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length.
Brahm NC; Washington NB
J Pharm Pract; 2011 Dec; 24(6):561-3. PubMed ID: 22048930
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the efficacy of haloperidol decanoate].
Alvarez JV; Li Gambi M
Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
Gelders YG
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
[TBL] [Abstract][Full Text] [Related]
10. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy.
arap Mengech HN; Wazome EG
East Afr Med J; 1984 Jun; 61(6):435-8. PubMed ID: 6152736
[No Abstract] [Full Text] [Related]
12. Alopecia areata associated with haloperidol decanoate long-acting injection.
Bhattacharya A; Roy D; Hazarika S; Das S; Nath K; Saddichha S
Aust N Z J Psychiatry; 2012 Jan; 46(1):69. PubMed ID: 22247099
[No Abstract] [Full Text] [Related]
13. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
14. Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate.
Kane JM
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):20S-23S. PubMed ID: 2870088
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
[TBL] [Abstract][Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
17. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
Bransgrove LL; Kelly MW
Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
[TBL] [Abstract][Full Text] [Related]
18. A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Wistedt B
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():15-23. PubMed ID: 3549878
[TBL] [Abstract][Full Text] [Related]
19. Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol.
Jhee SS; Zarotsky V; Mohaupt SM; Yones CL; Sims SJ
Ann Pharmacother; 2003 Oct; 37(10):1434-7. PubMed ID: 14519055
[TBL] [Abstract][Full Text] [Related]
20. 19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate.
Sassa T; Suhara T; Ikehira H; Obata T; Girard F; Tanada S; Okubo Y
Psychiatry Clin Neurosci; 2002 Dec; 56(6):637-42. PubMed ID: 12485307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
